Press Releases

Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG) 

ALXN

Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG)

BMV:ORBIA


Orbia Advance Corporation, S.A.B. de C.V. (BMV:ORBIA) (&#34;the Company&#34; or &#34;Orbia&#34;) today released unaudited results for the first quarter of 2024.


Orbia&#39;s first quarter performance reflects the continued weakness in the

Orbia Announces First Quarter 2024 Financial Results


AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an

AHF Praises Colombia for Putting Lives Before Pharma Greed


Freeport-McMoRan Inc. (NYSE:FCX) today announced the publication of its 2023 Annual Report on Sustainability detailing its environmental, social and governance performance during the year. This report marks FCX&#39;s 23rd

Freeport-McMoRan Publishes 2023 Annual Report on Sustainability



Delivers $0.36 of diluted earnings per share (EPS), a slight year-over-year decrease of $0.01



Invests $69 million in infrastructure



Secures 10.01% Water Cost of Capital Mechanism (WCCM)-adjusted return on equity

SJW Group Announces First Quarter 2024 Financial Results

TBBB


BBB Foods Inc. (&#34;Tiendas 3B&#34; or the &#34;Company&#34;) (NYSE:TBBB), a leading grocery hard discounter in Mexico, announced today its consolidated results for the fourth quarter of 2023 (4Q23) and full fiscal year 2023 ended

Tiendas 3B 4Q23 &amp; FY2023 Earnings Release


MoneyLion Inc. (&#34;MoneyLion&#34;) (NYSE:ML), a leader in financial technology powering the next generation of personalized products and content, today announced its participation at the following investor conferences in